Juvenile rheumatoid arthritis.
D000974:Antibodies, Antinuclear / Q000032:analysis; D000962:Antimalarials / Q000627:therapeutic use; D001171:Arthritis, Juvenile / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D001241:Aspirin / Q000627:therapeutic use; D001799:Blood Sedimentation; D002648:Child; D003165:Complement System Proteins / Q000032:analysis; D003348:Cortisone / Q000008:administration & dosage / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007213:Indomethacin / Q000627:therapeutic use; D007841:Latex Fixation Tests; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis; D010653:Phenylbutazone / Q000627:therapeutic use
D000974:Antibodies, Antinuclear; D000962:Antimalarials; D007136:Immunoglobulins; D006046:Gold; D003165:Complement System Proteins; D010653:Phenylbutazone; D001241:Aspirin; D003348:Cortisone; D007213:Indomethacin